Clinical Trials Support Services Market Size, Share & Trends Analysis Report By Phases (Phase I, Phase II, Phase III, Phase IV), By Service, By Sponsor, By Region (North America, Europe, APAC), And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 2 Business Days
Clinical Trials Support Services Market Growth & Trends
The global clinical trials support services market size is expected treach USD 37.16 billion in 2030 and is projected tgrow at a CAGR of 7.72% from 2025 t2030. Increasing the number of CROs offering clinical trial support services, and huge investment in research & development by the pharmaceutical and biopharmaceutical companies are the key factors driving the market growth. The industry felt the impact of the COVID-19 pandemic. The pandemic disrupted the supply chain ta severe extent in 2020. However, it alsrevealed ways tgrow, either through M&A or through the adoption of digital technologies in clinical research.
Clinical trials encounter some concerning statistics, such as 85% of the clinical trials fail trecruit enough participants, 80% are delayed due trecruiting challenges, and the rate of dropout of participants is increasing. However, tovercome this, a patient retention strategy that is engaging and gives clarity is required. It is critical tensure that the informed consent materials are simple tgrasp. According ta CISCRP study, 35% of trial participants whlater dropped out stated that informed consent was difficult tcomprehend. An average American is 7th t8th grade educated, and it is critical tguarantee and analyze the material’s readability before submitting it tthe Institutional Review Board (IRB).
Adoption of virtual clinical trials across the clinical trials support services industry is one of the major factors that has boosted revenue growth post-pandemic. An increasing number of clinical research organizations are focusing on the adoption of virtual technologies tstreamline their clinical research services. According tthe latest Annual CRO Report by the Veeva Unified Clinical Operations Survey, CROs are making significant advancements tspeed up and modernize clinical trials. Findings from Veeva Systems reflect that CROs have taken decisive action tstreamline trial execution by adopting new technologies and digital strategies that replace manual processes, eradicate information siloes, and enable trial collaborations.
Clinical Trials Support Services Market Report Highlights
Clinical Trials Support Services Market Growth & Trends
The global clinical trials support services market size is expected treach USD 37.16 billion in 2030 and is projected tgrow at a CAGR of 7.72% from 2025 t2030. Increasing the number of CROs offering clinical trial support services, and huge investment in research & development by the pharmaceutical and biopharmaceutical companies are the key factors driving the market growth. The industry felt the impact of the COVID-19 pandemic. The pandemic disrupted the supply chain ta severe extent in 2020. However, it alsrevealed ways tgrow, either through M&A or through the adoption of digital technologies in clinical research.
Clinical trials encounter some concerning statistics, such as 85% of the clinical trials fail trecruit enough participants, 80% are delayed due trecruiting challenges, and the rate of dropout of participants is increasing. However, tovercome this, a patient retention strategy that is engaging and gives clarity is required. It is critical tensure that the informed consent materials are simple tgrasp. According ta CISCRP study, 35% of trial participants whlater dropped out stated that informed consent was difficult tcomprehend. An average American is 7th t8th grade educated, and it is critical tguarantee and analyze the material’s readability before submitting it tthe Institutional Review Board (IRB).
Adoption of virtual clinical trials across the clinical trials support services industry is one of the major factors that has boosted revenue growth post-pandemic. An increasing number of clinical research organizations are focusing on the adoption of virtual technologies tstreamline their clinical research services. According tthe latest Annual CRO Report by the Veeva Unified Clinical Operations Survey, CROs are making significant advancements tspeed up and modernize clinical trials. Findings from Veeva Systems reflect that CROs have taken decisive action tstreamline trial execution by adopting new technologies and digital strategies that replace manual processes, eradicate information siloes, and enable trial collaborations.
Clinical Trials Support Services Market Report Highlights
- The clinical trial site management accounted for the largest market share of 45.73% in 2024.. High cost associated with site monitoring and site recruitment is one the key factors for the largest share.
- The phase III segment dominated the market, accounting for a revenue share of 54.43%. Phase III clinical trials are highly expensive due tthe involvement of huge subjects. The failure rate in this phase is the highest as the sample size and study design require complex dosing at an optimum level.
- Pharmaceutical & biopharmaceutical companies' segment dominated the market with the largest revenue share of 70.80% in 2024. Increasing R&D investments and the introduction of new drugs are primarily driving the segment market.
- North America dominated the global market in 2024 with the largest share of 48.80%, as most pharmaceutical businesses in the U.S. perform most of their business in this region
CHAPTER 1. RESEARCH METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Phases
1.2.2. Service
1.2.3. Sponsor
1.3. Regional Scope
1.4. Estimates And Forecast Timeline
1.5. Objectives
1.5.1. Objective-1
1.5.2. Objective-2
1.5.3. Objective-3
1.6. Research Methodology
1.7. Information Procurement
1.7.1. Purchased Database
1.7.2. GVR’s Internal Database
1.7.3. Secondary Sources
1.7.4. Primary Research
1.8. Information Or Data Analysis
1.8.1. Data Analysis Models
1.9. Market Formulation & Validation
1.10. Model Details
1.10.1. Commodity Flow Analysis
1.10.2. Parent Market Analysis
1.11. List Of Secondary Sources
1.12. List Of Abbreviations
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. CLINICAL TRIALS SUPPORT SERVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Clinical Trials Support Services Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
3.3.4. Major Deals & Strategic Alliances Analysis
CHAPTER 4. CLINICAL TRIALS SUPPORT SERVICES MARKET: PHASES ESTIMATES & TREND ANALYSIS
4.1. Clinical Trials Support Services Market, By Phases: Segment Dashboard
4.2. Clinical Trials Support Services Market, By Phases: Movement Analysis
4.3. Clinical Trials Support Services Market Estimates & Forecasts, By Phases, 2018 - 2030
4.4. Phase I
4.4.1. Phase I Market, 2018 to 2030 (USD Million)
4.4.2. Clinical Trial Site Management
4.4.2.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
4.4.3. Patient Recruitment Management
4.4.3.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
4.4.4. Data Management
4.4.4.1. Data Management Market, 2018 to 2030 (USD Million)
4.4.5. Administrative Staff
4.4.5.1. Administrative Staff Market, 2018 to 2030 (USD Million)
4.4.6. IRB
4.4.6.1. IRB Market, 2018 to 2030 (USD Million)
4.4.7. Others
4.4.7.1. Others Market, 2018 to 2030 (USD Million)
4.5. Phase II
4.5.1. Phase II Market, 2018 to 2030 (USD Million)
4.5.2. Clinical Trial Site Management
4.5.2.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
4.5.3. Patient Recruitment Management
4.5.3.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
4.5.4. Data Management
4.5.4.1. Data Management Market, 2018 to 2030 (USD Million)
4.5.5. Administrative Staff
4.5.5.1. Administrative Staff Market, 2018 to 2030 (USD Million)
4.5.6. IRB
4.5.6.1. IRB Market, 2018 to 2030 (USD Million)
4.5.7. Others
4.5.7.1. Others Market, 2018 to 2030 (USD Million)
4.6. Phase III
4.6.1. Phase III Market, 2018 to 2030 (USD Million)
4.6.2. Clinical Trial Site Management
4.6.2.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
4.6.3. Patient Recruitment Management
4.6.3.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
4.6.4. Data Management
4.6.4.1. Data Management Market, 2018 to 2030 (USD Million)
4.6.5. Administrative Staff
4.6.5.1. Administrative Staff Market, 2018 to 2030 (USD Million)
4.6.6. IRB
4.6.6.1. IRB Market, 2018 to 2030 (USD Million)
4.6.7. Others
4.6.7.1. Others Market, 2018 to 2030 (USD Million)
4.7. Phase IV
4.7.1. Phase IV Market, 2018 to 2030 (USD Million)
4.7.2. Clinical Trial Site Management
4.7.2.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
4.7.3. Patient Recruitment Management
4.7.3.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
4.7.4. Data Management
4.7.4.1. Data Management Market, 2018 to 2030 (USD Million)
4.7.5. Administrative Staff
4.7.5.1. Administrative Staff Market, 2018 to 2030 (USD Million)
4.7.6. IRB
4.7.6.1. IRB Market, 2018 to 2030 (USD Million)
4.7.7. Others
4.7.7.1. Others Market, 2018 to 2030 (USD Million)
CHAPTER 5. CLINICAL TRIALS SUPPORT SERVICES MARKET: SERVICE ESTIMATES & TREND ANALYSIS
5.1. Clinical Trials Support Services Market, By Service: Segment Dashboard
5.2. Clinical Trials Support Services Market, By Service: Movement Analysis
5.3. Clinical Trials Support Services Market Estimates & Forecasts, By Service, 2018 - 2030
5.4. Clinical Trial Site Management
5.4.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
5.5. Patient Recruitment Management
5.5.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
5.5.2. Patient recruitment & Registry Services
5.5.2.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
5.5.3. Patient retention
5.5.3.1. Patient Retention Market, 2018 to 2030 (USD Million)
5.5.4. Others
5.5.4.1. Others Market, 2018 to 2030 (USD Million)
5.6. Data Management
5.6.1. Data Management Market, 2018 to 2030 (USD Million)
5.7. Administrative Staff
5.7.1. Administrative Staff Market, 2018 to 2030 (USD Million)
5.8. IRB
5.8.1. IRB Market, 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Others Market, 2018 to 2030 (USD Million)
CHAPTER 6. CLINICAL TRIALS SUPPORT SERVICES MARKET: SPONSOR ESTIMATES & TREND ANALYSIS
6.1. Clinical Trials Support Services Market, By Sponsor: Segment Dashboard
6.2. Clinical Trials Support Services Market, By Sponsor: Movement Analysis
6.3. Clinical Trials Support Services Market Estimates & Forecasts, By Sponsor, 2018 - 2030
6.4. Pharmaceutical & biopharmaceutical companies
6.4.1. Pharmaceutical & biopharmaceutical companies Market, 2018 to 2030 (USD Million)
6.5. Medical device companies
6.5.1. Medical device companies Market, 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Others Market, 2018 to 2030 (USD Million)
CHAPTER 7. CLINICAL TRIALS SUPPORT SERVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. North America Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030
7.5. Europe
7.5.1. Europe Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030
7.5.7. Sweden
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
7.5.8. Denmark
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030
7.6. Asia Pacific
7.6.1. Asia Pacific Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030
7.6.5. Thailand
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030
7.6.7. Australia
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030
7.7. Latin America
7.7.1. Latin America Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
7.7.4. Colombia
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
7.8. MEA
7.8.1. MEA Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Market Participant Categorization
8.2. Company Market Share Analysis, 2023
8.3. Company Profiles
8.3.1. Charles River Laboratories International, Inc.
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Service Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Wuxi Apptec, Inc
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Service Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Iqvia Holdings, Inc
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Service Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Syneos Health, Inc.
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Service Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Eurofins Scientific
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Service Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. PPD, Inc. (Pharmaceutical Product Development)
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Service Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Icon Plc
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Service Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Laboratory Corporation of America Holdings (Labcorp)
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Service Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Alcura
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Service Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Parexel International Corporation
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Service Benchmarking
8.3.10.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Phases
1.2.2. Service
1.2.3. Sponsor
1.3. Regional Scope
1.4. Estimates And Forecast Timeline
1.5. Objectives
1.5.1. Objective-1
1.5.2. Objective-2
1.5.3. Objective-3
1.6. Research Methodology
1.7. Information Procurement
1.7.1. Purchased Database
1.7.2. GVR’s Internal Database
1.7.3. Secondary Sources
1.7.4. Primary Research
1.8. Information Or Data Analysis
1.8.1. Data Analysis Models
1.9. Market Formulation & Validation
1.10. Model Details
1.10.1. Commodity Flow Analysis
1.10.2. Parent Market Analysis
1.11. List Of Secondary Sources
1.12. List Of Abbreviations
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. CLINICAL TRIALS SUPPORT SERVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Clinical Trials Support Services Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
3.3.4. Major Deals & Strategic Alliances Analysis
CHAPTER 4. CLINICAL TRIALS SUPPORT SERVICES MARKET: PHASES ESTIMATES & TREND ANALYSIS
4.1. Clinical Trials Support Services Market, By Phases: Segment Dashboard
4.2. Clinical Trials Support Services Market, By Phases: Movement Analysis
4.3. Clinical Trials Support Services Market Estimates & Forecasts, By Phases, 2018 - 2030
4.4. Phase I
4.4.1. Phase I Market, 2018 to 2030 (USD Million)
4.4.2. Clinical Trial Site Management
4.4.2.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
4.4.3. Patient Recruitment Management
4.4.3.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
4.4.4. Data Management
4.4.4.1. Data Management Market, 2018 to 2030 (USD Million)
4.4.5. Administrative Staff
4.4.5.1. Administrative Staff Market, 2018 to 2030 (USD Million)
4.4.6. IRB
4.4.6.1. IRB Market, 2018 to 2030 (USD Million)
4.4.7. Others
4.4.7.1. Others Market, 2018 to 2030 (USD Million)
4.5. Phase II
4.5.1. Phase II Market, 2018 to 2030 (USD Million)
4.5.2. Clinical Trial Site Management
4.5.2.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
4.5.3. Patient Recruitment Management
4.5.3.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
4.5.4. Data Management
4.5.4.1. Data Management Market, 2018 to 2030 (USD Million)
4.5.5. Administrative Staff
4.5.5.1. Administrative Staff Market, 2018 to 2030 (USD Million)
4.5.6. IRB
4.5.6.1. IRB Market, 2018 to 2030 (USD Million)
4.5.7. Others
4.5.7.1. Others Market, 2018 to 2030 (USD Million)
4.6. Phase III
4.6.1. Phase III Market, 2018 to 2030 (USD Million)
4.6.2. Clinical Trial Site Management
4.6.2.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
4.6.3. Patient Recruitment Management
4.6.3.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
4.6.4. Data Management
4.6.4.1. Data Management Market, 2018 to 2030 (USD Million)
4.6.5. Administrative Staff
4.6.5.1. Administrative Staff Market, 2018 to 2030 (USD Million)
4.6.6. IRB
4.6.6.1. IRB Market, 2018 to 2030 (USD Million)
4.6.7. Others
4.6.7.1. Others Market, 2018 to 2030 (USD Million)
4.7. Phase IV
4.7.1. Phase IV Market, 2018 to 2030 (USD Million)
4.7.2. Clinical Trial Site Management
4.7.2.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
4.7.3. Patient Recruitment Management
4.7.3.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
4.7.4. Data Management
4.7.4.1. Data Management Market, 2018 to 2030 (USD Million)
4.7.5. Administrative Staff
4.7.5.1. Administrative Staff Market, 2018 to 2030 (USD Million)
4.7.6. IRB
4.7.6.1. IRB Market, 2018 to 2030 (USD Million)
4.7.7. Others
4.7.7.1. Others Market, 2018 to 2030 (USD Million)
CHAPTER 5. CLINICAL TRIALS SUPPORT SERVICES MARKET: SERVICE ESTIMATES & TREND ANALYSIS
5.1. Clinical Trials Support Services Market, By Service: Segment Dashboard
5.2. Clinical Trials Support Services Market, By Service: Movement Analysis
5.3. Clinical Trials Support Services Market Estimates & Forecasts, By Service, 2018 - 2030
5.4. Clinical Trial Site Management
5.4.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
5.5. Patient Recruitment Management
5.5.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
5.5.2. Patient recruitment & Registry Services
5.5.2.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
5.5.3. Patient retention
5.5.3.1. Patient Retention Market, 2018 to 2030 (USD Million)
5.5.4. Others
5.5.4.1. Others Market, 2018 to 2030 (USD Million)
5.6. Data Management
5.6.1. Data Management Market, 2018 to 2030 (USD Million)
5.7. Administrative Staff
5.7.1. Administrative Staff Market, 2018 to 2030 (USD Million)
5.8. IRB
5.8.1. IRB Market, 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Others Market, 2018 to 2030 (USD Million)
CHAPTER 6. CLINICAL TRIALS SUPPORT SERVICES MARKET: SPONSOR ESTIMATES & TREND ANALYSIS
6.1. Clinical Trials Support Services Market, By Sponsor: Segment Dashboard
6.2. Clinical Trials Support Services Market, By Sponsor: Movement Analysis
6.3. Clinical Trials Support Services Market Estimates & Forecasts, By Sponsor, 2018 - 2030
6.4. Pharmaceutical & biopharmaceutical companies
6.4.1. Pharmaceutical & biopharmaceutical companies Market, 2018 to 2030 (USD Million)
6.5. Medical device companies
6.5.1. Medical device companies Market, 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Others Market, 2018 to 2030 (USD Million)
CHAPTER 7. CLINICAL TRIALS SUPPORT SERVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. North America Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030
7.5. Europe
7.5.1. Europe Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030
7.5.7. Sweden
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
7.5.8. Denmark
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030
7.6. Asia Pacific
7.6.1. Asia Pacific Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030
7.6.5. Thailand
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030
7.6.7. Australia
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030
7.7. Latin America
7.7.1. Latin America Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
7.7.4. Colombia
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
7.8. MEA
7.8.1. MEA Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Market Participant Categorization
8.2. Company Market Share Analysis, 2023
8.3. Company Profiles
8.3.1. Charles River Laboratories International, Inc.
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Service Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Wuxi Apptec, Inc
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Service Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Iqvia Holdings, Inc
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Service Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Syneos Health, Inc.
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Service Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Eurofins Scientific
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Service Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. PPD, Inc. (Pharmaceutical Product Development)
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Service Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Icon Plc
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Service Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Laboratory Corporation of America Holdings (Labcorp)
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Service Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Alcura
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Service Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Parexel International Corporation
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Service Benchmarking
8.3.10.4. Strategic Initiatives
